Calling the shots

Billionaires, not politicians, bring potential COVID-19 vaccine to LatAm.

Argentinian President Fernández has recently announced that mAbxience (part of Grupo Insud, Argentina) and Laboratorios Liomont, S.A. (Mexico) have agreed a deal, with the financial backing of the Carlos Slim Foundation, for the entire region (excl. Brazil) to access a potential COVID-19 vaccine being developed by the University of Oxford and licensed to AstraZeneca.

The agreement is for the potential vaccine to be produced in Argentina before being packaged and distributed across Latin America through Mexico. For technical reasons apparently Sanofi and Liomont, with enormous production facilities in Mexico, don’t have capacity to produce the vaccine so Grupo Insud came to the rescue. Critics have an alternative theory, “Argentina is attractive for production because of weak intellectual property enforcement”.

“The deal is altruistic in public but lucrative in reality.”

Pharmaceutical company executive.

Grupo Insud’s owner, billionaire Hugo Sigman, seems to be at the centre of the deal and was at pains to stress this was a deal between private actors with no political involvement. This seems unlikely. According to our sources in Argentina, “Sigman is personal friend of Fernández, is close to Argentina’s Minister of Health, Ginés González García, and a good friend and donor to Juan Manzur, Governor of Tucumán, former Minister of Health under Kirchner and confidant of President Fernández”. Fernández and AMLO’s friendship is also no secret. Sigman also most likely brought in Slim, who is a close friend with shared business interests and also enjoys favour with the Argentinian government, “Fernandez has confessed an ideological affinity and admiration for Juan Manuel Abal Medina, Slim’s main advisor in Argentina”.

The arrangement could result in the production of 150-250 million doses at a price of 3-4 USD per dose (lower than the flu vaccine) because all parties have agreed not to profit from production: Slim’s charity is funding the costs and Insud is prepared to start production at risk. How generous! Our sources find it hard to believe that it will be entirely free, “Sigman’s links with the political world make it very clear that he will profit from this arrangement, one way or another”.

“It is an image-building move for businessmen and politicians to become heroes.”

Investigative healthcare expert.

So how clean is Sigman given his affinity for Kirchner’s administration which was well-known for corrupt practices? Well, two independent sources had questions around, “an agreement made in 2009 where the government agreed to acquire 30 million Avian Flu vaccine doses from Sigman, licensed from Novartis. This was far higher than deemed necessary, and apparently 65% to 70% of the doses went to waste. Ginés González García, the current Minister of Health and friend of Sigman and Fernández, and Juan Manzur, the Minister of Health at the time, were both involved in the purchase”. What a coincidence…

Let’s hope the COVID-19 vaccine doses don’t go to waste too!

Important Notice
While the information in this article has been prepared in good faith, no representation, warranty, assurance or undertaking (express or implied) is or will be made, and no responsibility or liability is or will be accepted by Deheza Limited or by its officers, employees or agents in relation to the adequacy, accuracy, completeness or reasonableness of this article, or of any other information (whether written or oral), notice or document supplied or otherwise made available in connection with this article. All and any such responsibility and liability is expressly disclaimed.
This article has been delivered to interested parties for information only. Deheza Limited gives no undertaking to provide the recipient with access to any additional information or to update this article or any additional information, or to correct any inaccuracies in it which may become apparent.

Most recent in Health

Cellular level 

Brazil’s cell and gene therapy industry. 

Battling the Buzz

Dengue wars in Latin America.

Galloping Ahead

Argentina’s cloning industry breaks new ground.

Revolutionising pharmaceutical services 

Challenges and opportunities in the Americas. 

LatAm’s fight for a healthier tomorrow

The region's efforts to defeat Hepatitis.

Diabetes spikes

A public health crisis is emerging as diabetes runs rampant across Latin America.

Sleep on it

A recent study claims 3 in 4 Argentinians suffer from some form of sleep disturbance.

Health collapse

Chile’s private health insurance companies face bankruptcy at the hands of government legislation.

Cholera outbreak

PAHO delivers over a million cholera vaccine doses to Haiti as outbreak gathers pace.

Birth dearth

Latin America’s fertility rate continues to fall but what does this mean for the region?